Evaluation of cardiovascular risk in a lung cancer screening cohort

Figures

• 

  Figure 1. Flow diagram for study participants. CHD, coronary heart disease; LCS, lung cancer screening; LDCT, low-dose computed tomography; LHC, lung health check; LSUT, Lung Screen Uptake Trial.

• 

  Figure 2. Examples of participants with mild (A,B), moderate (C,D) and heavy (E,F) coronary artery calcification.

• 

  Figure 3. QRISK2 score distribution for each visually determined CAC grade on LDCT. The boxes contain the 25th to 75th QRISK2 scores within each category, with the median value represented by a solid line running through the box. The whiskers extend to the upper and lower adjacent values and the dots represent the outliers. An extra horizontal dotted line has been added to demonstrate the threshold for initiation of statin therapy for primary prevention in the UK (10%). Posthoc p values corrected for multiple comparisons between group medians are highlighted. CAC, coronary artery calcification; LDCT, low-dose computed tomography.